This company has shut down. EIP Pharma is no longer operating — its last tracked round was a Grant in 2023.
Explore the Startup GraveyardEIP Pharma is a clinical stage therapeutics company developing drugs to treat neurodegenerative diseases.
EIP Pharma has raised $21.0M in total funding. The most recent round was Grant. The last funding was announced in January 2023.
EIP Pharma's investors include Access Industries, National Institute on Aging.
EIP Pharma is headquartered in Boston, United States.
EIP Pharma is a clinical stage therapeutics company developing drugs to treat neurodegenerative diseases.
EIP Pharma is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EIP Pharma — Funding & Investors." VCBacked, January 18, 2023, https://www.vcbacked.co/company/eip-pharma. Accessed August 14, 2026.
VCBacked. (2023). EIP Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/eip-pharma
{{cite web |title=EIP Pharma — Funding & Investors |url=https://www.vcbacked.co/company/eip-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated